Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

PURPOSE: Adoptive immunotherapy using tumor-infiltrating lymphocytes represents an effective cancer treatment for patients with metastatic melanoma. The NY-ESO-1 cancer/testis antigen, which is expressed in 80% of patients with synovial cell sarcoma and approximately 25% of patients with melanoma an...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Robbins, Paul F., Morgan, Richard A., Feldman, Steven A., Yang, James C., Sherry, Richard M., Dudley, Mark E., Wunderlich, John R., Nahvi, Azam V., Helman, Lee J., Mackall, Crystal L., Kammula, Udai S., Hughes, Marybeth S., Restifo, Nicholas P., Raffeld, Mark, Lee, Chyi-Chia Richard, Levy, Catherine L., Li, Yong F., El-Gamil, Mona, Schwarz, Susan L., Laurencot, Carolyn, Rosenberg, Steven A.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Clinical Oncology 2011
נושאים:
Original Reports
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068063/
https://ncbi.nlm.nih.gov/pubmed/21282551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.2537
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים